INOTIV INC (NOTV) Stock Price & Overview

NASDAQ:NOTV • US45783Q1004

Current stock price

0.2668 USD
+0.01 (+2.42%)
At close:
0.2576 USD
-0.01 (-3.45%)
After Hours:

The current stock price of NOTV is 0.2668 USD. Today NOTV is up by 2.42%. In the past month the price decreased by -19.64%. In the past year, price decreased by -88.65%.

NOTV Key Statistics

52-Week Range0.2439 - 3.32
Current NOTV stock price positioned within its 52-week range.
1-Month Range0.2439 - 0.4846
Current NOTV stock price positioned within its 1-month range.
Market Cap
9.175M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.03
Dividend Yield
N/A

NOTV Stock Performance

Today
+2.42%
1 Week
-2.27%
1 Month
-19.64%
3 Months
-50.32%
Longer-term
6 Months -81.73%
1 Year -88.65%
2 Years -93.05%
3 Years -95.18%
5 Years -98.87%
10 Years N/A

NOTV Stock Chart

INOTIV INC / NOTV Daily stock chart

NOTV Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to NOTV. When comparing the yearly performance of all stocks, NOTV is a bad performer in the overall market: 97.89% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NOTV Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NOTV. NOTV has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NOTV Earnings

On February 9, 2026 NOTV reported an EPS of -0.83 and a revenue of 120.88M. The company missed EPS expectations (-27.14% surprise) and missed revenue expectations (-1.99% surprise).

Next Earnings DateMay 5, 2026
Last Earnings DateFeb 9, 2026
PeriodQ1 / 2026
EPS Reported-$0.83
Revenue Reported120.879M
EPS Surprise -27.14%
Revenue Surprise -1.99%

NOTV Forecast & Estimates

8 analysts have analysed NOTV and the average price target is 3.06 USD. This implies a price increase of 1046.93% is expected in the next year compared to the current price of 0.2668.

For the next year, analysts expect an EPS growth of -4.07% and a revenue growth 3.73% for NOTV


Analysts
Analysts82.5
Price Target3.06 (1046.93%)
EPS Next Y-4.07%
Revenue Next Year3.73%

NOTV Groups

Sector & Classification

NOTV Financial Highlights

Over the last trailing twelve months NOTV reported a non-GAAP Earnings per Share(EPS) of -2.03. The EPS increased by 55.97% compared to the year before.


Income Statements
Revenue(TTM)514.03M
Net Income(TTM)-69.37M
Industry RankSector Rank
PM (TTM) N/A
ROA -9.45%
ROE -63.63%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%18.63%
Sales Q2Q%0.84%
EPS 1Y (TTM)55.97%
Revenue 1Y (TTM)8.19%

NOTV Ownership

Ownership
Inst Owners22.64%
Shares34.39M
Float31.08M
Ins Owners9.59%
Short Float %10.06%
Short Ratio6.6

About NOTV

Company Profile

NOTV logo image Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,945 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Company Info

IPO: 1997-11-25

INOTIV INC

2701 Kent Ave

West Lafayette INDIANA 47906 US

CEO: Robert W. Leasure Jr.

Employees: 1945

NOTV Company Website

NOTV Investor Relations

Phone: 13174634527

INOTIV INC / NOTV FAQ

Can you describe the business of INOTIV INC?

Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,945 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.


What is the current price of NOTV stock?

The current stock price of NOTV is 0.2668 USD. The price increased by 2.42% in the last trading session.


Does INOTIV INC pay dividends?

NOTV does not pay a dividend.


What is the ChartMill technical and fundamental rating of NOTV stock?

NOTV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the GICS sector and industry of NOTV stock?

INOTIV INC (NOTV) operates in the Health Care sector and the Life Sciences Tools & Services industry.


How is the valuation of INOTIV INC (NOTV) based on its PE ratio?

INOTIV INC (NOTV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.03).


What is INOTIV INC worth?

INOTIV INC (NOTV) has a market capitalization of 9.18M USD. This makes NOTV a Nano Cap stock.